MOLN•benzinga•
Molecular Partners Presents New Preclinical Data On Radio-DARPin And Switch-DARPin Programs At AACR 2025; First Preclinical Data Of Novel Targeted Radio-DARPin Against Mesothelin, In Co-Development With Orano Med
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 25, 2025 by benzinga